Template:Heparin reversal: Difference between revisions

(Created page with "*'''Major bleeding due to unfractionated heparin:''' **1 mg IV for every 100 units of heparin infused in past 3h **Do not infuse faster than 50mg/10min **If it has been >30mi...")
 
No edit summary
 
Line 3: Line 3:
**Do not infuse faster than 50mg/10min
**Do not infuse faster than 50mg/10min
**If it has been >30min since last heparin injection, 0.5mg may be sufficient
**If it has been >30min since last heparin injection, 0.5mg may be sufficient
**Give slowly over 1-3min; do not exceed 50mg in any 10 minute period ([[anaphylaxis ]] risk)
**Because half-life is short (7 min) may require second treatment
*Major bleeding due to low-molecular-weight heparin:
*Major bleeding due to low-molecular-weight heparin:
**Protamine is less effective for bleeding from LMWH than it is with heparin-induced bleeds
**Protamine is less effective for bleeding from LMWH than it is with heparin-induced bleeds
**'''Enoxaparin:''' 1 mg IV for every 1 mg enoxaparin administered in past 8h
**'''Enoxaparin:''' 1 mg IV for every 1 mg enoxaparin administered in past 8h
**'''Dalteparin:''' 1 mg IV for every 100 anti-Xa international units of dalteparin
**'''Dalteparin:''' 1 mg IV for every 100 anti-Xa international units of dalteparin

Latest revision as of 15:07, 6 July 2022

  • Major bleeding due to unfractionated heparin:
    • 1 mg IV for every 100 units of heparin infused in past 3h
    • Do not infuse faster than 50mg/10min
    • If it has been >30min since last heparin injection, 0.5mg may be sufficient
    • Give slowly over 1-3min; do not exceed 50mg in any 10 minute period (anaphylaxis risk)
    • Because half-life is short (7 min) may require second treatment
  • Major bleeding due to low-molecular-weight heparin:
    • Protamine is less effective for bleeding from LMWH than it is with heparin-induced bleeds
    • Enoxaparin: 1 mg IV for every 1 mg enoxaparin administered in past 8h
    • Dalteparin: 1 mg IV for every 100 anti-Xa international units of dalteparin